Wang Dan, Du Xiao-Xi
Center for Drug Evaluation, State Food and prug Administration, Beijing 100045, China.
Zhongguo Zhong Yao Za Zhi. 2012 Sep;37(18):2686-8.
The newly revised Regulations for the Administration of Adverse Drug Reaction Reporting and monitoringhas been implemented since July 1, 2011. It is the most important regulation on adverse drug reaction (ADR) monitoring. This article will intensively read the regulation and analysis its significance on the traditional Chinese medicine adverse reaction monitoring, so as to make the revised content more clear and guide the ADR monitoring working better.
新修订的《药品不良反应报告和监测管理办法》自2011年7月1日起施行。它是关于药品不良反应监测最重要的法规。本文将深入研读该法规并分析其对中药不良反应监测的意义,以便使修订内容更加清晰,更好地指导药品不良反应监测工作。